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The serum  thymic factor  (FTS)  has been chemically characterized by its capacity 
to induce T  cell markers on  bone marrow cells (1).  It is a  nonapeptide whose amino 
acid  sequence  has  been  determined  (2).  Recently,  we  demonstrated  (3)  that  FTS 
binds  the  metal  zinc  that  appears  to  be essential  for  the  biological activity of the 
hormone.  Lastly, data from  our  laboratory and  other laboratories have shown  that 
FTS binds to high-affinity receptors (4) and induces a whole set ofT  cell markers and 
functions (1). 
The  thymic  origin  of  FTS  is  indicated  by  its  presence  in  thymic  extracts  (5). 
Moreover,  using immunofluorescence,  the presence of FTS within  thymic epithelial 
reticular  cells  (ERC)  has  been  recently  reported  in  mouse  and  man  (6-7),  using 
different  anti-FTS  antisera.  These  data  have  been  confirmed  by  immunoelectron 
microscopy  (8).  Nevertheless,  newly  published  evidence  of  an  FTS  or  FTS-like 
immunoreactivity in several other epithelial tissues  (9)  has raised some doubts as to 
the thymic specificity of FTS origin. 
In  the  present  study,  we  describe  the  characterization  and  distribution  of FTS- 
containing cells in  mouse  thymus,  as revealed by anti-FTS  monoclonal  antibodies. 
The thymic specificity of FTS-containing cells is demonstrated by the negative results 
obtained with several other epithelial tissues. 
Materials  and  Methods 
Preparation  of Anti-FTS  Monoclonal  Antibodies.  Four different monoclonal antibodies (IgGl, 
IgG2,, and IgM) were produced (10).  The concentration of monoclonal immunoglobulin (Ig) 
present in the ascitic fluid varied between 6 and  15 mg/ml. 
Immunofluorescence Technique.  20 mice of the C57BL/6 strain, aged 4-6 wk, were used. The 
thymus was excised and frozen in liquid nitrogen. Unfixed cryostatic sections (2/*m thick) were 
processed as described elsewhere (7,  10). As controls, thynms sections were incubated with (a) 
GAM-FITC  conjugate  only;  (b)  anti-FTS  ascites  previously  absorbed  with  synthetic  FTS 
(10  -a M)  overnight at  4°C  and  30 min at  37°C;  and  (c)  two unrelated antibody-containing 
ascites. 
To ascertain the thymic specificity of the FTS+  cells, sections of spleen, skin, esophagus, 
stomach, gut, liver, trachea, kidney, urinary bladder, and salivary glands, obtained from both 
normal and nude mice, were submitted to the four anti-FTS ascites. To determine whether the 
same cell was able to fix two different anti-FTS monoclonal antibodies, we performed double- 
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labeling experiments, using GAM-FITC and GAM-IgG1/TRITC as conjugates. The possibility 
that  one  anti-FTS  ascites  could  recognize some  but  not  all  FTS+  cells  was  examined  by 
counting the number of fluorescent cells both after incubation of sections with a single ascites 
and with a pool of the different anti-FTS ascites. 
Characterization of FTS-immunoreactive Cells 
The epithelial nature of FTS-immunoreactive cells was approached by performing a double 
labeling of thymic sections and of cultured thymic reticular cells with an anti-FTS ascites and 
an anti-keratin xenoantiserum and by studying thymic phagocytes as controls. 
THYM1C  RETICULAR CELL CULTURES.  Thymic  reticular  cells  were  cultured  as  described 
elsewhere (11). In brief, C57BL/6 thymus fragments were cultivated for 12 d in muhiwell tissue 
culture plates (Linbro Chemical Co., Hamden, CT) containing plastic coverslips. 
ISOLATION OF THYMIC MACROPHAC,  ES.  Thymic macrophages were concentrated on a  Ficoll 
gradient as described previously (12). Cells of the lighter layers were distributed onto the  15- 
mm plastic coverslips in the wells of Linbro plates. 4 h later, coverslips were recovered and the 
adherent cells were studied by immunofluorescence. 
Results 
Demonstration of FTS-immunoreactive Cells in the Thymus 
FROZEN SECTIONS.  The four anti-FTS-containing ascites succeeded in demonstrat- 
ing the presence of fluorescent cells within the thymic parenchyma (Fig.  1). The same 
patterns  of brightness  as  well  as  the  number  of positive cells were  observed  with 
dilutions of ascites ranging from  1/1 to  1/100,000.  All control experiments, including 
the  absorption  of the  anti-FTS  ascites  with  FTS,  were  negative.  All other  organs, 
either from normal or nude mice, were also negative. Double labeling, using different 
Fro.  I.  5-wk-old  C57BL/6  mouse thymus. The frozen section was incubaled  with an  anti-FTS 
monoclonal antibody and lhen with GAM/FITC. Several leTS+ cells can be observed. × 500. 630  SAVINO  ET  AL  BRIEF  DEFINITIVE  REPORT 
FIG,  2.  Double-labeling immunofluorescence on a  C57BL/6 mouse thymus section. An anti-FTS 
monoclonal antibody of the IgC-2, subclass was visualized by a  GAM/FITC  (a), whereas an  I~(L 
anti-FTS  monoclonal  antibndv  was  visualized  bv  a  C-AM  (Igf.~)/'I'RITC  (b).  The  same cell  is 
marked by both anti-FTS antibodies. X 750. 
Fro.  3.  Double-labeling immunofluorescence on  a  section  from  a  C57BL/6  mouse thymus. An 
I~,Jl  anti-FTS monoclonal antibody was visualized by a  GAM (IgGI)/TRITC  (a), and a  purified 
anti-keratin antiserum was visualized by a GAR/FITC  (b). In the medullary region of this thymic 
lobule, among the many epithelial cells labeled by the anti-keratin antiserum, one cell (arrows ill a 
and b) contains FTS. X 500. 
anti-FTS  ascites,  showed  that  the  four  monoclonal  antibodies  recognized  the  same 
cells  (Fig.  2).  Furthermore,  approximately  the  same  number  of FTS-containing  cells 
was  found  after  incubating  the  sections  with  either  one  ascites  or  a  pool  of the  four 
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FIG. 4.  Thymus section from a C57BL/6 mouse.  The anti-FTS monoclonal  antibody was visualized 
by a GAM-FITC. This low magnification micrograph shows the topographic distribution of FTS- 
containing cells within the thymic lobule. The greater majority of FTS+ cells are concentrated in 
the medullary region, although one cell (arrow) can be seen in the cortex. ×  150. Inset, an FTS+ 
cell showing a cytoplasmic process and a cell body in which the nucleus appears as a negative 
image. X 500~ 
Thymic Reticular Cultures.  FTS+  cells could  also  be  demonstrated in cultures of 
thymic reticulum. Immunofluorescence was seen in cytoplasmic granules of the cells. 
As observed for frozen sections, all controls were negative. 
Characterization of the Epithelial Nature of the FTS-immunoreactive Cells.  Double-labeling 
experiments using an anti-FTS ascites and an anti-keratin antiserum revealed that 
FTS-containing cells fixed the anti-keratin antibody, but their number was largely 
inferior to  the  total  number of keratin-positive cells  (Fig.  3).  Similar results  were 
observed on cultured thymic reticular cells. The anti-FTS antibody did not bind to 
isolated thymic macrophages used as controls. 
Distribution of FTS-immunoreactive Cells in the Thymus.  Although they were observed 
in both the cortex and medulla of thymic lobules, FTS+ cells were found to be much 
more frequent in the medullary region, where ~ 1% of the epithelial cells were labeled 
(Fig. 4). Comparative evaluation indicated that the number of FTS+ cells was about 
ten times higher in the medulla than in the cortex. The shape and size of FTS+ cells 
varied, but slender fluorescent cytoplasmic processes  were  the  most  frequently ob- 
served characteristic. In some FTS+ cells, the cytoplasm showed fluorescent granules 
present in the cell body and in the cytoplasmic processes.  Rare Hassall's corpuscles 
could be seen in the mouse thymus; some of them showed FTS-immunoreactivity  in 
their periphery. 
Discussion 
This  paper  provides  the  first  characterization  and  topographic  localization  of 632  SAVINO ET AL.  BRIEF  DEFINITIVE REPORT 
thymic hormone-containing cells in the thymus using monoclonal antibodies. The use 
of FTS-reactive monoclonal antibodies and adequate controls assessed the specificity 
of the immuno-histologic technique.  These results confirm and extend those recently 
reported  using  xenogeneic  anti-FTS  rabbit  antisera  (6-7).  The  fact  that  mouse 
antibodies reacted well with mouse thymic epithelial cells suggests that the reactivity 
of FTS with the monoclonal antibodies is essentially of the autoimmune type. It must 
be noted, however, that the same antibodies have been recently shown to react with 
human thymus (unpublished data). The FTS-containing cells detected in this study 
should be considered as thymic epithelial cells because they are also marked by anti- 
keratin  antibodies  that  label  only epithelial  cells  (13).  Such  epithelial  nature  was 
demonstrated in tissue sections as well as in cultures of thymic epithelial  cells.  The 
possible role of purified thymic phagocytes was excluded, as they remained unmarked 
by the anti-FTS monoclonal antibody. 
Furthermore,  FTS-positive cells  were consistently  Ia negative  (data  not  shown). 
This observation, together with  the data  mentioned  above, leads  to the hypothesis 
that FTS-containing cells belong to a subpopulation of thymic epithelial cells included 
in the minor subpopulation of Ia-negative epithelial cells. 
The serum thymic factor is not  the only lymphocyte-differentiating peptide pro- 
duced by the thymic epithelium. One may assume that distinct  cells are specialized 
in  the  production  of each peptide.  Such  possibility has recently been suggested by 
Hirokawa  et  al.  (14),  who  showed  that  human  thymic  epithelial  cells  containing 
thymosin-al  and thymosin-fl3 are distinct  cells and are located in different areas of 
the  thymic  lobules.  Another  possibility  (not  excluding  the  preceeding  one)  is  that 
FTS-producing cells store various amounts of FTS and that  at a  given time only a 
minority of these cells are revealed by immunofluorescence. 
Our study provides some insight into the distribution of FTS-containing cells in the 
thymic  parenchyma.  FTS-positive cells  are  located  in  the  cortical  and  medullary 
regions  of  the  thymus,  confirming  the  results  previously  found  with  polyclonal 
xenogeneic anti-FTS sera (7).  On the other hand,  the heterogeneous distribution  of 
FTS+ cells within a given thymic lobule, with a strong predominance of these cells in 
the medulla, has not been described before. This distribution  is in keeping with the 
well-known concentration of epithelial reticular cells in the medulla. 
Last,  this  work  brings  further  direct  arguments  in  favor of the  exclusive thymic 
origin of FTS. We did not find any positive binding of the anti-FTS monoclonals in 
any other epithelial tissues. This finding fits with those of Monier (6) and Jambon (7) 
but is at variance with the recent report by Kato et al. (9), who described the presence 
of FTS-immunoreactive cells in several epithelial  tissues.  It is possible that  the anti- 
FTS sera produced by Kato et al. recognize an antigenic determinant  that, although 
present on the FTS molecule, is not recognized by our monoclonal antibodies or other 
xenogeneic  antisera.  Such  determinant  could  also  occur  in  some  FTS-related  sub- 
stances common to several epithelial tissues. 
In any case, the fact that, when using our FTS-specific monoclonal antibodies, we 
detect  FTS+  cells only in  the  thymus,  and  that  FTS  disappears  from serum  after 
thymectomy, demonstrates the exclusive thymic production of the FTS molecule. 
Summary 
The characterization  and distribution  of cells containing  the serum thymic factor 
(FTS)  in  the  thymus  of  young  mice  was  studied  by  immunofluorescence  using SAVINO ET AL.  BRIEF  DEFINITIVE REPORT  633 
monoclonal anti-FTS antibodies.  FTS+ cells were distributed  throughout the thymic 
parenchyma but were more frequent  in the medullary region than  in the cortex. 
FTS-containing  cells  presented  a  stellate  or  globular  aspect,  and  some  of them 
exhibited  fluorescent cytoplasmic granules.  The epithelial  nature  of FTS+ cells was 
confirmed  by  double-labeling  experiments  using  an  anti-keratin  antiserum  (as  an 
epithelial  cell  marker).  Nevertheless,  only  a  minority  of keratin-positive  epithelial 
reticular cells contained FTS. 
All controls, including the incubation  of sections from nonthymic tissues with the 
anti-FTS antibodies, were negative. Taken together, these results confirm the exclusive 
localization of FTS-containing cells within the mouse thymus. 
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